The Latest Cardiac and Vascular News
The Biome Performance Manager™ simplifies and accelerates clinical and financial performance improvement across cardiovascular subspecialties. Clinicians, care teams, and hospital leadership leverage scarce resources to manage more initiatives, achieve goals faster, and sustain gains. SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leader in clinical performance solutions, is pleased to announce the release […]
Dr. Rakesh Arora to lead cardiac intensive care units and cardiac surgery research CLEVELAND – University Hospitals (UH) Harrington Heart & Vascular Institute has a rich history of providing the highest level of care for patients. Continuing as leaders in this field and elevating cardiac surgery patient care to a […]
UChicago Alumnus Antonio Gracias’ Family Foundation Invests in Early-Stage Atherosclerosis Research at The Pritzker School of Molecular Engineering The Gracias Family Foundation has committed $3 million to new early-stage nanomedicine research led by the University of Chicago’s Pritzker School of Molecular Engineering aimed at reducing atherosclerosis, the inflammation of the […]
Industry veterans Vanessa Joyce named VP of Sales for North America and Megan Grosz appointed Head of Global Marketing and Communications CAMBRIDGE, Mass., Sept. 28, 2022 /PRNewswire/ — Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced its continued growth with the appointment of two new senior-level executives. Vanessa Joyce was named the Company’s new Vice President […]
— If 510(k) cleared, this next-generation investigational inhaled nitric oxide delivery system would be the latest in a long line of dual channel delivery systems building on Company’s dedication to meeting clinicians’ evolving needs — DUBLIN, Sept. 28, 2022 /PRNewswire/ — Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced the submission of a […]
Program to Provide $100,000 in Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular and Neuromuscular Diseases Deadline for Applications is November 11th, 2022 SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced a call for proposals for the fifth […]
Patented Technology Allows HeartBeam AIMIGo™ Credit Card-sized Device to Enable a 12-lead ECG Anytime, Anywhere SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today that its patent that enables generation of a […]
SAN DIEGO, Sept. 27, 2022 /PRNewswire/ — REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, today announced that enrollment in the MOTIV pivotal trial has been initiated at clinical centers in both the U.S. and Europe. The study will evaluate the use of the MOTIV® Sirolimus-Eluting Bioresorbable Vascular Scaffold for […]
REVERSE-HF will evaluate ultrafiltration therapy in comparison to IV diuretics to treat heart failure patients with fluid overload MINNEAPOLIS, Sept. 27, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the activation of three additional sites […]
Midline options designed to fit the needs of clinicians and patients WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) releases their new Arrow® Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion. Clinicians can choose between the Arrowg+ard Blue Advance® Midline […]
